Home Blood Pressure Variability

  • Gianfranco ParatiEmail author
  • Juan Eugenio Ochoa
  • Yutaka Imai
  • Anastasios Kollias
  • Efstathios Manios
  • Takayoshi Ohkubo
  • Kazuomi Kario
  • George S. Stergiou
  • Grzegorz Bilo
Part of the Updates in Hypertension and Cardiovascular Protection book series (UHCP)


A series of studies in the last decades have indicated that the risk of cardiovascular complications may not only depend on the magnitude of the elevation of average BP levels per se but also on an increased blood pressure variability. This concept has been supported by several reports, showing that increasing values of blood pressure variability either in the short term (24 h), in the midterm (day-by-day), or in the long term (visit-to-visit), may contribute to cardiovascular risk prediction over and above the impact of average BP levels. This chapter will focus on the day-by-day variations in BP values self-measured at home by patients, by addressing their mechanisms, the methodological aspects that should be considered for their assessment based on home BP measurements as well as their clinical relevance for cardiovascular prognosis. We will also address some yet pending issues which still make application of day-by-day Home Blood Pressure (HBP) variability difficult in daily practice. These include the additional contribution given by HBP variability to risk prediction, on top of what is offered by average HBP levels, and whether antihypertensive treatment strategies should be targeted at reducing not only average BP levels but also the degree of day-by-day blood pressure variability in order to optimize cardiovascular protection.


Home blood pressure variability (HBPV) Cardiovascular risk Antihypertensive treatment Cardiovascular protection Home blood pressure monitoring (HBPM) 


  1. 1.
    Parati G, Ochoa JE, Lombardi C, Bilo G. Assessment and management of blood-pressure variability. Nat Rev Cardiol. 2013;10(3):143–55.CrossRefGoogle Scholar
  2. 2.
    Parati G, Ochoa JE, Bilo G. Blood pressure variability, cardiovascular risk, and risk for renal disease progression. Curr Hypertens Rep. 2012;14(5):421–31.CrossRefGoogle Scholar
  3. 3.
    Murakami S, Otsuka K, Kubo Y, Shinagawa M, Matsuoka O, Yamanaka T, et al. Weekly variation of home and ambulatory blood pressure and relation between arterial stiffness and blood pressure measurements in community-dwelling hypertensives. Clin Exp Hypertens. 2005;27:231–9.CrossRefGoogle Scholar
  4. 4.
    Niiranen TJ, Hanninen MR, Johansson J, Reunanen A, Jula AM. Home-measured blood pressure is a stronger predictor of cardiovascular risk than office blood pressure: the Finn-Home study. Hypertension. 2010;55(6):1346–51.CrossRefGoogle Scholar
  5. 5.
    Thijs L, Staessen JA, Celis H, Fagard R, De Cort P, de Gaudemaris R, et al. The international database of self-recorded blood pressures in normotensive and untreated hypertensive subjects. Blood Press Monit. 1999;4(2):77–86.CrossRefGoogle Scholar
  6. 6.
    Nagai M, Hoshide S, Ishikawa J, Shimada K, Kario K. Visit-to-visit blood pressure variations: new independent determinants for carotid artery measures in the elderly at high risk of cardiovascular disease. J Am Soc Hypertens. 2011;5(3):184–92.CrossRefGoogle Scholar
  7. 7.
    Niiranen TJ, Asayama K, Thijs L, Johansson JK, Ohkubo T, Kikuya M, et al. Outcome-driven thresholds for home blood pressure measurement: international database of home blood pressure in relation to cardiovascular outcome. Hypertension. 2013;61(1):27–34.CrossRefGoogle Scholar
  8. 8.
    Okada T, Nakao T, Matsumoto H, Nagaoka Y, Tomaru R, Iwasawa H, et al. Day-by-day variability of home blood pressure in patients with chronic kidney disease. Nihon Jinzo Gakkai shi. 2008;50(5):588–96.PubMedGoogle Scholar
  9. 9.
    Kato T, Kikuya M, Ohkubo T, Satoh M, Hara A, Obara T, et al. Factors associated with day-by-day variability of self-measured blood pressure at home: the Ohasama study. Am J Hypertens. 2010;23(9):980–6.CrossRefGoogle Scholar
  10. 10.
    Cacciolati C, Tzourio C, Hanon O. Blood pressure variability in elderly persons with white-coat and masked hypertension compared to those with normotension and sustained hypertension. Am J Hypertens. 2013;26(3):367–72.CrossRefGoogle Scholar
  11. 11.
    Ishikura K, Obara T, Kato T, Kikuya M, Shibamiya T, Shinki T, et al. Associations between day-by-day variability in blood pressure measured at home and antihypertensive drugs: the J-HOME-morning study. Clin Exp Hypertens. 2012;34(4):297–304.CrossRefGoogle Scholar
  12. 12.
    O’Brien E, Parati G, Stergiou G, Asmar R, Beilin L, Bilo G, et al. European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens. 2013;31(9):1731–68.CrossRefGoogle Scholar
  13. 13.
    Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 practice guidelines for the management of arterial hypertension of the European Society of Hypertension and the European Society of Cardiology: ESH/ESC task force for the Management of Arterial Hypertension. J Hypertens. 2018;36(12):2284–309.CrossRefGoogle Scholar
  14. 14.
    Parati G, Stergiou G, O’Brien E, Asmar R, Beilin L, Bilo G, et al. European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens. 2014;32(7):1359–66.CrossRefGoogle Scholar
  15. 15.
    Stergiou GS, Parati G, Vlachopoulos C, Achimastos A, Andreadis E, Asmar R, et al. Methodology and technology for peripheral and central blood pressure and blood pressure variability measurement: current status and future directions - position statement of the European Society of Hypertension Working Group on blood pressure monitoring and cardiovascular variability. J Hypertens. 2016;34(9):1665–77.CrossRefGoogle Scholar
  16. 16.
    Parati G, Stergiou GS, Asmar R, Bilo G, de Leeuw P, Imai Y, et al. European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the second international consensus conference on home blood pressure monitoring. J Hypertens. 2008;26(8):1505–26.CrossRefGoogle Scholar
  17. 17.
    Stergiou GS, Parati G, McManus RJ, Head GA, Myers MG, Whelton PK. Guidelines for blood pressure measurement: development over 30 years. J Clin Hypertens (Greenwich). 2018;20(7):1089–91.CrossRefGoogle Scholar
  18. 18.
    Juhanoja EP, Niiranen TJ, Johansson JK, Puukka PJ, Thijs L, Asayama K, et al. Outcome-driven thresholds for increased home blood pressure variability. Hypertension. 2017;69(4):599–607.CrossRefGoogle Scholar
  19. 19.
    Johansson JK, Niiranen TJ, Puukka PJ, Jula AM. Prognostic value of the variability in home-measured blood pressure and heart rate: the Finn-home study. Hypertension. 2012;59(2):212–8.CrossRefGoogle Scholar
  20. 20.
    Asayama K, Kikuya M, Schutte R, Thijs L, Hosaka M, Satoh M, et al. Home blood pressure variability as cardiovascular risk factor in the population of Ohasama. Hypertension. 2013;61(1):61–9.CrossRefGoogle Scholar
  21. 21.
    Asayama K, Ohkubo T, Hanazawa T, Watabe D, Hosaka M, Satoh M, et al. Does antihypertensive drug class affect day-to-day variability of self-measured home blood pressure? The HOMED-BP study. J Am Heart Assoc. 2016;5(3):e002995.CrossRefGoogle Scholar
  22. 22.
    Stergiou GS, Ntineri A, Kollias A, Ohkubo T, Imai Y, Parati G. Blood pressure variability assessed by home measurements: a systematic review. Hypertens Res. 2014;37(6):565–72.CrossRefGoogle Scholar
  23. 23.
    di Rienzo M, Grassi G, Pedotti A, Mancia G. Continuous vs intermittent blood pressure measurements in estimating 24-hour average blood pressure. Hypertension. 1983;5(2):264–9.CrossRefGoogle Scholar
  24. 24.
    Mancia G, Di Rienzo M, Parati G. Ambulatory blood pressure monitoring use in hypertension research and clinical practice. Hypertension. 1993;21(4):510–24.CrossRefGoogle Scholar
  25. 25.
    Mena L, Pintos S, Queipo NV, Aizpurua JA, Maestre G, Sulbaran T. A reliable index for the prognostic significance of blood pressure variability. J Hypertens. 2005;23(3):505–11.CrossRefGoogle Scholar
  26. 26.
    Hansen TW, Thijs L, Li Y, Boggia J, Kikuya M, Bjorklund-Bodegard K, et al. Prognostic value of reading-to-reading blood pressure variability over 24 hours in 8938 subjects from 11 populations. Hypertension. 2010;55(4):1049–57.CrossRefGoogle Scholar
  27. 27.
    Rothwell PM, Howard SC, Dolan E, O’Brien E, Dobson JE, Dahlof B, et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet. 2010;375(9718):895–905.CrossRefGoogle Scholar
  28. 28.
    Veloudi P, Blizzard CL, Head GA, Abhayaratna WP, Stowasser M, Sharman JE. Blood pressure variability and prediction of target organ damage in patients with uncomplicated hypertension. Am J Hypertens. 2016;29(9):1046–54.CrossRefGoogle Scholar
  29. 29.
    Wei FF, Li Y, Zhang L, Xu TY, Ding FH, Wang JG, et al. Beat-to-beat, reading-to-reading, and day-to-day blood pressure variability in relation to organ damage in untreated Chinese. Hypertension. 2014;63(4):790–6.CrossRefGoogle Scholar
  30. 30.
    Shibasaki S, Hoshide S, Eguchi K, Ishikawa J, Kario K. Japan morning surge-home blood pressure study G. Increase trend in home blood pressure on a single occasion is associated with B-type natriuretic peptide and the estimated glomerular filtration rate. Am J Hypertens. 2015;28(9):1098–105.CrossRefGoogle Scholar
  31. 31.
    Ushigome E, Fukui M, Hamaguchi M, Tanaka T, Atsuta H, Mogami S, et al. Maximum home systolic blood pressure is a useful indicator of arterial stiffness in patients with type 2 diabetes mellitus: post hoc analysis of a cross-sectional multicenter study. Diabetes Res Clin Pract. 2014;105(3):344–51.CrossRefGoogle Scholar
  32. 32.
    Liu Z, Zhao Y, Lu F, Zhang H, Diao Y. Day-by-day variability in self-measured blood pressure at home: effects on carotid artery atherosclerosis, brachial flow-mediated dilation, and endothelin-1 in normotensive and mild-moderate hypertensive individuals. Blood Press Monit. 2013;18(6):316–25.CrossRefGoogle Scholar
  33. 33.
    Matsui Y, O’Rourke MF, Hoshide S, Ishikawa J, Shimada K, Kario K. Combined effect of angiotensin II receptor blocker and either a calcium channel blocker or diuretic on day-by-day variability of home blood pressure: the Japan combined treatment with Olmesartan and a Calcium-Channel blocker versus Olmesartan and diuretics randomized efficacy study. Hypertension. 2012;59(6):1132–8.CrossRefGoogle Scholar
  34. 34.
    Ushigome E, Fukui M, Hamaguchi M, Senmaru T, Sakabe K, Tanaka M, et al. The coefficient variation of home blood pressure is a novel factor associated with macroalbuminuria in type 2 diabetes mellitus. Hypertens Res. 2011;34(12):1271–5.CrossRefGoogle Scholar
  35. 35.
    Matsui Y, Ishikawa J, Eguchi K, Shibasaki S, Shimada K, Kario K. Maximum value of home blood pressure: a novel indicator of target organ damage in hypertension. Hypertension. 2011;57(6):1087–93.CrossRefGoogle Scholar
  36. 36.
    Stevens SL, Wood S, Koshiaris C, Law K, Glasziou P, Stevens RJ, et al. Blood pressure variability and cardiovascular disease: systematic review and meta-analysis. BMJ. 2016;354:i4098.CrossRefGoogle Scholar
  37. 37.
    Ohkubo T, Asayama K, Kikuya M, Metoki H, Hoshi H, Hashimoto J, et al. How many times should blood pressure be measured at home for better prediction of stroke risk? Ten-year follow-up results from the Ohasama study. J Hypertens. 2004;22(6):1099–104.CrossRefGoogle Scholar
  38. 38.
    Ntineri A, Kalogeropoulos PG, Kyriakoulis KG, Aissopou EK, Thomopoulou G, Kollias A, et al. Prognostic value of average home blood pressure and variability: 19-year follow-up of the Didima study. J Hypertens. 2018;36(1):69–76.CrossRefGoogle Scholar
  39. 39.
    Hoshide S, Yano Y, Mizuno H, Kanegae H, Kario K. Day-by-day variability of home blood pressure and incident cardiovascular disease in clinical practice: the J-HOP study (Japan morning surge-home blood pressure). Hypertension. 2018;71(1):177–84.CrossRefGoogle Scholar
  40. 40.
    Hoshide S, Yano Y, Shimizu M, Eguchi K, Ishikawa J, Kario K. Is home blood pressure variability itself an interventional target beyond lowering mean home blood pressure during anti-hypertensive treatment? Hypertens Res. 2012;35(8):862–6.CrossRefGoogle Scholar

Copyright information

© The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG, part of Springer Nature 2020

Authors and Affiliations

  • Gianfranco Parati
    • 1
    • 2
    Email author
  • Juan Eugenio Ochoa
    • 3
  • Yutaka Imai
    • 4
  • Anastasios Kollias
    • 5
  • Efstathios Manios
    • 6
  • Takayoshi Ohkubo
    • 4
    • 7
  • Kazuomi Kario
    • 8
  • George S. Stergiou
    • 5
  • Grzegorz Bilo
    • 9
    • 10
  1. 1.Department of Medicine and SurgeryUniversity of Milano-BicoccaMilanItaly
  2. 2.Istituto Auxologico Italiano, IRCCS, Department of CardiovascularNeural and Metabolic SciencesMilanItaly
  3. 3.Istituto Auxologico Italiano, IRCCS, Department of Cardiovascular Neural and Metabolic SciencesMilanItaly
  4. 4.Tohoku Institute for Management of Blood PressureSendaiJapan
  5. 5.Hypertension Center STRIDE-7, National and Kapodistrian University of Athens, School of Medicine, Third Department of Medicine, Sotiria HospitalAthensGreece
  6. 6.Department of Clinical TherapeuticsNational and Kapodistrian University of Athens, Medical School, Alexandra HospitalAthensGreece
  7. 7.Department of Hygiene and Public HealthTeikyo University School of MedicineTokyoJapan
  8. 8.Division of Cardiovascular Medicine, Department of MedicineJichi Medical University School of Medicine (JMU)TochigiJapan
  9. 9.Istituto Auxologico Italiano, IRCCS, Department of Cardiovascular Neural and Metabolic SciencesMilanItaly
  10. 10.Department of Medicine and SurgeryUniversity of Milano-BicoccaMilanItaly

Personalised recommendations